Schizophrenia
899 results
401 - 500
Lurasidone versus typical antipsychotics for schizophrenia- Antidepressants for people with both schizophrenia and depression
Psychoeducation (brief) for people with schizophrenia - Dietary advice for people with schizophrenia
- Haloperidol versus first-generation antipsychotic drugs for schizophrenia
- Antipsychotic medication for elderly people with schizophrenia
- Selective noradrenaline reuptake inhibitors for schizophrenia
- Sulpiride versus placebo for schizophrenia
- Risperidone versus other atypical antipsychotics for schizophrenia
- Yoga versus non‐standard care for schizophrenia
- Atypical antipsychotics for people with both schizophrenia and depression
- Aripiprazole versus brexpiprazole for people with schizophrenia
- Monetary incentives for schizophrenia
- Acetylcholinesterase inhibitors for schizophrenia
- Ziprasidone versus other atypical antipsychotics for schizophrenia
- Perphenazine for schizophrenia
- Fluphenazine (oral) versus placebo for schizophrenia
- Haloperidol dose for the acute phase of schizophrenia
- Risk assessment for aggressive behaviour in schizophrenia
- Levomepromazine for schizophrenia
- Risperidone vs. other atypical antipsychotic medication for schizophrenia
- Olanzapine versus other atypical antipsychotics for schizophrenia
- Thioridazine for schizophrenia
- Trifluoperazine versus placebo for schizophrenia: Cochrane systematic review
- Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
- Sulpiride augmentation for schizophrenia
- Haloperidol dose for the acute phase of schizophrenia
- Antioxidant treatments for schizophrenia: Cochrane systematic review
- Magnetic seizure therapy for people with schizophrenia
- Cognitive behavioural therapy without medication for schizophrenia
- Risperidone versus typical antipsychotic medication for schizophrenia
- Modafinil for people with schizophrenia or related disorders
- Transitional discharge interventions for people with schizophrenia
- Cognitive rehabilitation for people with schizophrenia and related conditions
- Haloperidol versus placebo for schizophrenia
- Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses
- Amisulpride versus other atypical antipsychotics for schizophrenia
- Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
- Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
- Acupuncture for schizophrenia
- Humour‐based interventions for people with schizophrenia
- Antidepressants for the negative symptoms of schizophrenia
- Transcranial magnetic stimulation (TMS) for schizophrenia
- Antipsychotic medication for childhood‐onset schizophrenia
- Antipsychotic combinations for schizophrenia
- Distraction techniques for schizophrenia
- Depot haloperidol decanoate for schizophrenia
- Intermittent drug techniques for schizophrenia
- Chlorpromazine versus penfluridol for schizophrenia
- Bromperidol decanoate (depot) for schizophrenia: Cochrane systematic review
- Increasing antipsychotic dose for non response in schizophrenia
- Maintenance treatment with antipsychotic drugs for schizophrenia
- Zotepine versus other atypical antipsychotics for schizophrenia
- Cognitive behavioural therapy (brief versus standard duration) for schizophrenia
- Yoga versus standard care for schizophrenia
- Mirtazapine adjunct for people with schizophrenia
- Chlorpromazine versus placebo for schizophrenia
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
- Haloperidol discontinuation for people with schizophrenia
- Video games for people with schizophrenia
- Electroconvulsive therapy for schizophrenia: Cochrane systematic review
- Family intervention for schizophrenia
- Twenty‐four hour care for schizophrenia
- Interventions for smoking cessation and reduction in individuals with schizophrenia
- Penfluridol for schizophrenia
- Clozapine versus typical neuroleptic medication for schizophrenia: Cochrane systematic review
- Family‐based interventions versus standard care for people with schizophrenia
- Pimozide for schizophrenia or related psychoses: Cochrane systematic review
- Benzodiazepines for schizophrenia: Cochrane systematic review
- Sulpiride for schizophrenia: Cochrane systematic review
- Quetiapine versus other atypical antipsychotics for schizophrenia
- Cognitive behavioural therapy (group) for schizophrenia
- Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
- Chinese herbal medicine for schizophrenia
- Asenapine versus placebo for schizophrenia
- Risperidone versus other atypical antipsychotic medication for schizophrenia: Cochrane systematic review
- Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
- Family intervention (brief) for schizophrenia
- Parenting interventions for people with schizophrenia or related serious mental illness
- Sertindole for schizophrenia
- Morita therapy for schizophrenia
- Risperidone (depot) for schizophrenia
- Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
- Nidotherapy for people with schizophrenia
- Flupenthixol versus placebo for schizophrenia
- Lamotrigine for schizophrenia: Cochrane systematic review
- Electroconvulsive therapy for treatment‐resistant schizophrenia
- Olanzapine for schizophrenia: Cochrane systematic review
- Social skills programmes for schizophrenia
- Bifeprunox versus placebo for schizophrenia
- Molindone for schizophrenia and severe mental illness: Cochrane systematic review
- Outcome measures and needs assessment tools for schizophrenia and related disorders